Literature DB >> 2511942

Non-biological factors in day to day variation of heparin requirements.

A G Fennerty1, M N Levine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511942      PMCID: PMC1837883          DOI: 10.1136/bmj.299.6706.1012

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  In vivo accuracy of gravity-flow i.v. infusion systems.

Authors:  R E Crass; J R Vance
Journal:  Am J Hosp Pharm       Date:  1985-02

Review 2.  Anticoagulants in venous thromboembolism.

Authors:  A Fennerty; I A Campbell; P A Routledge
Journal:  BMJ       Date:  1988-11-19

3.  Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions.

Authors:  A M van den Besselaar; J Meeuwisse-Braun; R Jansen-Grüter; R M Bertina
Journal:  Thromb Haemost       Date:  1987-04-07       Impact factor: 5.249

  3 in total
  1 in total

Review 1.  Intravenous heparin dosing: patterns and variations in internists' practices.

Authors:  B M Reilly; R Raschke; S Srinivas; T Nieman
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.